bluebird bio to Present at Two Upcoming Health Care Conferences Read more about bluebird bio to Present at Two Upcoming Health Care Conferences
bluebird bio Appoints Mark Vachon to its Board of Directors Read more about bluebird bio Appoints Mark Vachon to its Board of Directors
bluebird bio Announces Pricing of Public Offering of Common Stock Read more about bluebird bio Announces Pricing of Public Offering of Common Stock
bluebird bio Announces Proposed Public Offering of Common Stock Read more about bluebird bio Announces Proposed Public Offering of Common Stock
bluebird bio Acquires Precision Genome Engineering, a Privately Held Gene-Editing Company Read more about bluebird bio Acquires Precision Genome Engineering, a Privately Held Gene-Editing Company
bluebird bio Reports Rapid Transfusion Independence in Beta-Thalassemia Major Patients Treated with its LentiGlobin Product Candidate Read more about bluebird bio Reports Rapid Transfusion Independence in Beta-Thalassemia Major Patients Treated with its LentiGlobin Product Candidate
bluebird bio to Host a Conference Call to Discuss Initial Results from the HGB-205 Study in Beta-Thalassemia Major Subjects Read more about bluebird bio to Host a Conference Call to Discuss Initial Results from the HGB-205 Study in Beta-Thalassemia Major Subjects
bluebird bio to present initial clinical data from its HGB-205 Study in beta-thalassemia major patients at the 19th European Hematology Association Congress Read more about bluebird bio to present initial clinical data from its HGB-205 Study in beta-thalassemia major patients at the 19th European Hematology Association Congress
bluebird bio Reports Fiscal First Quarter 2014 Financial Results Read more about bluebird bio Reports Fiscal First Quarter 2014 Financial Results
bluebird bio to Present at Three Upcoming Health Care Conferences Read more about bluebird bio to Present at Three Upcoming Health Care Conferences